CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07739589
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-08-28T00:09:08.319196+00:00
Published At: 2026-08-27T00:00:00+00:00
Record Updated At: 2026-08-27
Results Posted At: 2026-08-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Residual Drug Amount of EE and LNG"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-27"
protocolSection.identificationModule.nctId: "NCT07739589"
protocolSection.identificationModule.officialTitle: "A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA\u00ae (Levonorgestrel and Ethinyl Estradiol) Transdermal System"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-08-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.